Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Januglip 100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Januglip 100

Approved

STANDARD

Januglip 100

Hebei Tiancheng Pharmaceutical Co., Ltd🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ab71edd48c1de46a
Company: Hebei Tiancheng Pharmaceutical Co., Ltd
Type: Standard

Approval Details

Approval Id: ab71edd48c1de46a
Drug Approval Philippines Name: Januglip 100
Product Name: Januglip 100
Registration Number: DRP-10623-02
Brand Name: Januglip 100
Generic Name: Sitagliptin (as phosphate)
Dosage Form: Tablet
Dosage Strength: 100 mg
Manufacturer: Hebei Tiancheng Pharmaceutical Co., Ltd
Importer: AMB HK Enterprises Inc.
Distributor: FSPC Pharmaceuticals Inc.
Issuance Date: 28 February 2022
Expiry Date: 28 October 2026
Pharmacologic Category: Dipeptidyl peptidase 4 (DPP-4) Inhibitor
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ab71edd48c1de46a

Type

Standard

Back to Philippines FDA Approvals